Detalhe da pesquisa
1.
SGLT2 inhibitors therapy protects glucotoxicity-induced ß-cell failure in a mouse model of human KATP-induced diabetes through mitigation of oxidative and ER stress.
PLoS One
; 17(2): e0258054, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35180212